An international financial watchdog said on Friday member states should take action to ward off risks emanating from Iran and North Korea, which it said had failed to tackle money-laundering and financing of terrorism.
North Korea
The government of North Korea under Kim Jong-un appeared to be purging close allies of disgraced political leader and family member Chang Song-thaek as the former orders its business people in China to come home.
South Korea was reported to be a possible investor in Britain's nuclear power market after the Asian country hired Lloyd's Register to evaluate its nuclear reactors, according to a director at Lloyd's.
US and South Korea discussed the possibility of delaying wartime control transfer to South Korea's troops amidst fears of North Korea's weapons of mass destruction capabilities.
The two Koreas agreed to resume operations of the Kaesong industrial zone on a trial basis starting Monday.
Last Wednesday, North and South Korea said through a joint statement that it would reopen the Kaesong industrial zone to attract foreign investors.
North and South Korea announced that they had agreed to reopen the Kaesong industrial complex, which was closed when tensions grew between the two countries in April.
Subscribe to VCpost newsletter
Most Popular
- Neuralink Co-Founder Implies He Left Elon Musk's Brain Implant Company Over Safety Concerns
- Tennessee Cleaning Company Fined $650,000 for Illegally Hiring Children, Some as Young as 13, to Clean Dangerous Slaughterhouses
- New York Is the World's Richest City, With Its Millionaires and Billionaires' Wealth Greater Than GDPs of Brazil, Canada, Italy
- Mini Gold Bars Are Causing a Frenzy in South Korea as Buyers Rush to Get Them in Convenience Stores, Vending Machines
- AstraZeneca to Pull Out COVID-19 Vaccine Worldwide After Adverse Side Effect Admission
- Joe Biden Administration Sanctions Colombian Maritime Companies Preying on Vulnerable Migrants Seeking to Enter US
- Pfizer Settles 10,000 Zantac Heartburn Medication Lawsuits Over Cancer Risks
- Amgen Challenges Novo Nordisk, Eli Lilly in Weight Loss Drug Market as Investors Flock for Next Obesity Drug Payout